Followers

Tuesday, May 10, 2022

Covaxin Maker Gets $19 Million For Development Of 'Variant Proof' Vaccine

CEPI on Tuesday said it will provide up to USD 19.3 million (about Rs 149 crore) to Bharat Biotech International, the University of Sydney, and Switzerland-based ExcellGene SA for the development of a...

from NDTV News - Special https://ift.tt/HAad5FK

No comments:

Post a Comment

Investors moving away from stocks, going for MFs: Sebi

from Business News Today: Stock Markets, Financial News, India Business & World Business News https://ift.tt/D7OySoZ